|
Karbamazepin |
S, P (Li-heparin) |
![](data:image/jpeg;base64, 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) |
|
Za praćenje terapije uzorak se uzima u epruvetu BEZ GELA prije uzimanja jutarnje doze ili u slučajnom uzorku kod sumnje na predoziranost.. |
|
Fenobarbital |
S, P (Li-heparin) |
![](data:image/jpeg;base64, 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) |
|
Za praćenje terapije uzorak se uzima u epruvetu BEZ GELA prije uzimanja jutarnje doze ili u slučajnom uzorku kod sumnje na predoziranost. |
|
Sirolimus |
vK (K2 i K3EDTA) |
![](data:image/jpeg;base64, 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) |
|
Za praćenje terapije uzorak krvi se uzima prije uzimanja jutarnje doze. |
|
Takrolimus |
vK (K2 i K3EDTA) |
![](data:image/jpeg;base64, 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) |
|
Za praćenje terapije uzorak krvi se uzima prije uzimanja jutarnje doze. |
|
Ciklosporin |
vK (K2 i K3EDTA) |
![](data:image/jpeg;base64, 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) |
|
Za praćenje terapije uzorak krvi se uzima prije uzimanja jutarnje doze. |
|
Everolimus |
vK (K2 i K3EDTA) |
![](data:image/jpeg;base64, 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) |
|
Za praćenje terapije uzorak krvi se uzima prije uzimanja jutarnje doze. Izdavanje nalaza prvi idući četvrtak. |
|
Litij |
S |
![](data:image/jpeg;base64, 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) |
|
Za praćenje terapije uzorak krvi se uzima prije uzimanja jutarnje doze. |
|
Metotreksat |
S |
![](data:image/jpeg;base64, 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) |
|
|
|
Digoksin |
S, P (Li-heparin) |
![](data:image/jpeg;base64, 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) |
|
|
|
Levetiracetam |
S |
![](data:image/jpeg;base64, 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) |
|
|